Macquarie Group
RCEL icon

Macquarie Group’s Avita Medical RCEL Stock Holding History

Macquarie Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Buy
144,164
+132,262
+1,111% +$570K ﹤0.01% 700
2026
Q1 		$44K Buy
11,902
+10,145
+577% +$42.6K ﹤0.01% 796
2025
Q4 		$6.06K Sell
1,757
-19,692
-92% -$78.6K ﹤0.01% 834
2025
Q3 		$110K Sell
21,449
-4,677
-18% -$24.4K ﹤0.01% 1518
2025
Q2 		$138K Buy
+26,126
New +$190K ﹤0.01% 1561
2025
Q1 		– Sell
-623
Closed -$8 – 1781
2024
Q4 		$8 Sell
623
-241
-28% -$2.84K ﹤0.01% 1659
2024
Q3 		$9.26K Sell
864
-3,437
-80% -$32.3K ﹤0.01% 1630
2024
Q2 		$34.1K Buy
4,301
+3,318
+338% +$31.6K ﹤0.01% 1618
2024
Q1 		$16 Buy
983
+52
+6% +$842 ﹤0.01% 1705
2023
Q4 		$12.8K Sell
931
-910
-49% -$10.4K ﹤0.01% 1617
2023
Q3 		$26 Sell
1,841
-1,595
-46% -$27K ﹤0.01% 1644
2023
Q2 		$58.4K Sell
3,436
-892
-21% -$13.1K ﹤0.01% 1610
2023
Q1 		$60.5K Buy
+4,328
New +$46K ﹤0.01% 1630
2022
Q1 		– Sell
-26,176
Closed -$314K – 2639
2021
Q4 		$314K Sell
26,176
-5,700
-18% -$86.9K ﹤0.01% 1695
2021
Q3 		$565K Buy
31,876
+22,852
+253% +$431K ﹤0.01% 1670
2021
Q2 		$185K Buy
9,024
+8,448
+1,467% +$166K ﹤0.01% 1820
2021
Q1 		$11K Sell
576
-8,305
-94% -$193K ﹤0.01% 2382
2020
Q4 		$165K Sell
8,881
-3,406
-28% -$74.7K ﹤0.01% 1728
2020
Q3 		$375K Buy
+12,287
New +$306K ﹤0.01% 1474

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Macquarie Group's RCEL Position: Q2 2026 in Review

Macquarie Group increased its Avita Medical (RCEL) stake by 1,111% in Q2 2026, buying an estimated $570K and bringing the position to 144,164 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Macquarie Group first reported a position in RCEL in Q3 2020 and has held it in 19 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Macquarie Group held 144,164 shares of Avita Medical worth $595K as of Q2 2026.
  • Macquarie Group bought 132,262 Avita Medical shares in Q2 2026, an estimated $570K.
  • Avita Medical made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #700 holding.
  • Macquarie Group first reported a position in Avita Medical in Q3 2020 and has held it in 19 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.